Is a complete CABA research report available?

No complete published report is available for Cabaletta Bio, Inc. (CABA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Cabaletta Bio, Inc. (CABA)

NASDAQ: CABA · USD

$2.72

+0.10 (+3.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CABA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	443.5M
Net income (ttm)	-175.4M
EPS (ttm)	-$1.84
Shares out	163.1M
Volume	1,294,621
Beta	3.26
Price target	$13.4	+391.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -175.4M
EPS (ttm): -$1.84
Market cap: 443.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CABA indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001759138
Company name	Cabaletta Bio, Inc.
Country	United States
Country code	US
Cusip	12674W109
Employees	158
Employees Change	-9%
Employees Change Percent	-5.39
Enterprise value	$353.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-10-25
Isin	US12674W1099
Last refreshed	2026-07-31
Market cap	$443.5M
Market cap category	Small-Cap
Price	$2.72
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2836
Symbol	CABA
Website	https://www.cabalettabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-39.55%
FCF yield	-32.31%
P/B ratio	2.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-175.4M
Net Income Growth Years	0%
Profit Per Employee	$-1.1M
ROA	-71.58
Roa5y	-34.83
ROCE	-168.2
ROE	-156
Roe5y	-62.93
ROIC	-80.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	73.31%
Cagr3y	-40.29%
Cagr5y	-19.02%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$148.1M
Cash	$116.6M
Current Assets	$122.3M
Current Liabilities	$41.5M
Debt	$26.5M
Debt Equity	$0.26
Equity	$103.3M
Interest Coverage	-76.47
Liabilities	$44.8M
Long Term Assets	$25.8M
Long Term Liabilities	$3.3M
Net Cash	$90.2M
Net Cash By Market Cap	$20.33
Net Cash Growth	-12.47%
Net Debt Equity	$-0.87
Tangible Book Value	$103.3M
Tangible Book Value Per Share	$0.93
WACC	21.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.95
Net Working Capital	$-12.7M
Quick ratio	2.81
Working Capital	$80.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-90.89%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	73.25%
200-day SMA	2.86
3Y total return	-78.72%
50-day SMA	3.1
50-day SMA vs 200-day SMA	50over200
5Y total return	-65.17%
All Time High	26.35
All Time High Change	-89.68%
All Time High Date	2024-02-08
All Time Low	0.59
All Time Low Change	361.02%
All Time Low Date	2022-09-23
ATR	0.18
Beta	3.26
Beta1y	3.15
Beta2y	4.09
Ch YTD	24.2
High	2.73
High52	4.23
High52 Date	2026-05-06
High52ch	-35.7%
Low	2.63
Low52	1.26
Low52 Date	2025-08-12
Low52ch	115.87%
Ma50ch	-12.14%
Premarket Change Percent	2.29
Premarket Price	$2.68
Premarket Volume	11,704
Price vs 200-day SMA	-4.9%
RSI	43.14
RSI Monthly	43.37
RSI Weekly	46.6
Sharpe ratio	0.97x
Sortino ratio	1.94
Total Return	-90.89%
Tr YTD	24.2
Tr1m	-12.54%
Tr3m	-2.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	5
Analyst Price Target Top	$23
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.35
Operating Income	$-179.4M
Price target	$13.38
Price Target Change	$392
Price Target Change Top	$746

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	142,902,449%
Float Percent	87.64%
Net Borrowing	-9,980,000
Shares Insiders	1.01%
Shares Institutions	52.87%
Shares Out	163,054,796
Shares Qo Q	6.9%
Shares Yo Y	90.89%
Short Float	28.7%
Short Ratio	5.98
Short Shares	25.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-164.3M
Adjusted OCF	-163,873,000
Average Volume	4,020,347.25x
Bv Per Share	0.93
CAPEX	$-444,000
Ch1m	-12.54
Ch1y	73.25
Ch3m	-2.16
Ch3y	-78.72
Ch5y	-65.17
Ch6m	-1.09
Change	3.82%
Change From Open	2.64
Close	2.62
Days Gap	1.15
Depreciation Amortization	1,498,000
Dollar Volume	3,521,369.1
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-179.4M
EBITDA	$-177.9M
EPS	$-1.84
F Score	1
FCF	$-143.3M
FCF EV Yield	-40.55x
FCF Per Share	$-0.88
Financing CF	126,166,000
Fiscal Year End	December
Founded	2,017
Investing CF	1,479,000
Ipr	-75.27
Iprfo	-69.78
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-23
Ma150	2.98
Ma150ch	-8.57%
Ma20	2.84
Ma20ch	-4.12%
Net CF	-15,195,000
Next Earnings Date	2026-08-10
Open	2.65
Optionable	Yes
Position In Range	90
Ppne	20,557,000
Pre Close	2.62
Price Date	2026-07-30
Ptbv Ratio	4.29
Relative Volume	0.32x
Share Based Comp	21,034,000
Tr6m	-1.09%
Us State	Pennsylvania
Volume	1,294,621

Cabaletta Bio, Inc. (CABA)

Coverage state: Market snapshot only — no published research

Generate the first CABA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CABA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CABA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CABA

Frequently asked questions